Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-030912
Filing Date
2014-05-02
Accepted
2014-05-02 19:47:05
Documents
1
Period of Report
2014-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9872
  Complete submission text file 0001209191-14-030912.txt   11366
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 90 BOULEVARD PASTEUR, CS 21564 PARIS CEDEX 15 I0 75730
Business Address 90 BOULEVARD PASTEUR, CS 21564 PARIS CEDEX 15 I0 75730 33 1 76 33 34 83
F.C.P.R. Genavent (Reporting) CIK: 0001604069 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-36365 | Film No.: 14811001